ADMA Biologics
ADMA
ADMA
130 hedge funds and large institutions have $315M invested in ADMA Biologics in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 11 closing their positions.
Holders
130
Holders Change
+17
Holders Change %
+15.04%
% of All Funds
2.25%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
28
Increased
43
Reduced
33
Closed
11
Calls
$3.82M
Puts
$965K
Net Calls
+$2.86M
Net Calls Change
+$2M
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$22.9M |
2 |
2
Invesco
Atlanta,
Georgia
|
$8.33M |
3 |
FAM
3
Fred Alger Management
New York
|
$6.96M |
4 |
BCM
4
Bridgeway Capital Management
Houston,
Texas
|
$5.95M |
5 |
5
Nuveen Asset Management
Chicago,
Illinois
|
$21.2M |